[In vitro antibacteric activity of a combination of erythromycin, sulfadiazine, sulfamerazine and sulfamethazine on different bacterial strains].
D004357:Drug Synergism; D004917:Erythromycin / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects; D012485:Salmonella typhi / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013411:Sulfadiazine / Q000494:pharmacology*; D013416:Sulfamerazine / Q000494:pharmacology*; D013418:Sulfamethazine / Q000494:pharmacology*
D013411:Sulfadiazine; D013418:Sulfamethazine; D004917:Erythromycin; D013416:Sulfamerazine
Attività antibatterica in vitro di una associazione di eritromicina, sulfadiazina, sulfamerazina e sulfametazina su vari ceppi batterici.